Background. One aim of epidural analgesia during childbirth is to provide satisfactory pain relief with minimal side effects. We hypothesized that a combination of opioid and local anesthetic would better achieve this aim than either drug alone. This study compared the efficacy and side effects of epidural meperidine and bupivacaine combined to those of meperidine and bupivacaine alone.
Methods. One hundred consenting nulliparas requesting epidural analgesia in labor were randomly assigned to receive, in a double-blind fashion, one of five treatments. These were 25 mg meperidine, 12.5 mg bupivacaine, 25 mg meperidine plus 12.5 mg bupivacaine, 25 mg bupivacaine, and 37.5 mg bupivacaine. Efficacy of analgesia and side effects were assessed before and after each dose. Leg strength was measured with a force meter and blood flow to each foot with a blood perfusion monitor. The neurobehavioral state of the newborn was assessed by a pediatrician who was blind to treatment using a neurologic and adaptive capacity scoring system.
Results. Thirty-seven women did not achieve satisfactory analgesia after the first dose of test medication; these predominantly were those who received 25 mg meperidine ( n = 12) or 12.5 mg bupivacaine ( n = 11). Nausea decreased after the initial dose with all treatments ( p < 0.01), whereas shivering increased in patients receiving bupivacaine ( p < 0.01). There was a reduction in leg strength and an increase in blood flow associated with the two higher bupivacaine treatments ( p < 0.01), and with both parameters the dependent limb was most affected. Overall patient satisfaction was greatest in the group receiving meperidine plus bupivacaine. Neonatal neurologic and adaptive capacity scores did not differ significantly among the treatment groups.
Conclusion. The low-dose combination of meperidine and bupivacaine used in this trial proved a satisfactory preparation for epidural administration during the early stages of labor.
- Anesthetic techniques
Statistics from Altmetric.com
Supported by the Lennard Travers Professorship (PB), a Royal Australasian College of Surgeons, Melbourne, Faculty of Anaesthetists, Research Award, and Astra Pharmaceuticals, Pty Ltd., Australia.
The authors thank Ms. C.L. Odgers and Mr. L.C-P. Wu of the Department of Pharmacy for preparation of the coded syringes, Mr. C.F. McLean for blood drug analysis, and the midvives from our Labor and Delivery Suite.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.